Please login to the form below

Not currently logged in
Email:
Password:

Therachon

This page shows the latest Therachon news and features for those working in and with pharma, biotech and healthcare.

Pfizer buys dwarfism drug company Therachon for $810m

Pfizer buys dwarfism drug company Therachon for $810m

Will rival BioMarin pipeline drug. Pfizer is spending $340m to acquire Therachon, a European biotech with a drug in trials for achondroplasia, a form of short-limbed dwarfism. ... By acquiring Therachon, we hope to leverage Pfizer’s leading scientific

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Therachon poaches Shire’s Aled Williams Therachon poaches Shire’s Aled Williams

    Therachon, a clinical-stage biotechnology company, has appointed Aled Williams to the position of chief commercial officer and head of patient access. ... in developing TA-46, and advancing Therachon’s pipeline of drug candidates that aim to bring a

  • Therachon appoints Christian Meyer as chief medical officer Therachon appoints Christian Meyer as chief medical officer

    He succeeds Maarten Kraan who remains as an advisor. Therachon has appointed Christian Meyer as its new chief medical officer, a role that will see him succeed Maarten Kraan, who will ... Luca Santarelli, chief executive officer and director, Therachon,

  • Therachon appoints new chief medical officer Therachon appoints new chief medical officer

    him focus on the clinical development of TA-46 - Therachon’s leading drug in development for achondroplasia. ... Luca Santarelli, chief medical officer at Therachon, said: “Dr Kraan’s wealth of translational and drug development expertise is

  • Therachon strengthens management team Therachon strengthens management team

    MacroGenics. Meanwhile, Dr Schikan (pictured below right) joins Therachon's board as a non-executive director. ... Dr Luca Santarelli, Therachon's chief executive officer and director, said: “I am delighted to have Drs Schikan, Porter and Stavenhagen

More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....